Øystein Rekdal

Øystein Rekdal

Chief Executive Officer at LYTIX BIOPHARMA

34 connections
Health Technology
Consumer Services

Øystein Rekdal active positions

CompaniesPositionStartEnd
LYTIX BIOPHARMA Chief Executive Officer 11/09/2019 -
Founder 01/01/2003 -
Director/Board Member 26/04/2010 21/04/2011
Chief Tech/Sci/R&D Officer - 11/09/2019
Corporate Officer/Principal 01/01/2003 -
University of Tromso Corporate Officer/Principal - -

Career history of Øystein Rekdal

Former positions of Øystein Rekdal

CompaniesPositionStartEnd
Prophylix AS
Logo Prophylix AS

Prophylix AS

Pharmaceuticals: MajorHealth Technology

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

 Director/Board Member 15/04/2010 -

Training of Øystein Rekdal

University of Tromso Doctorate Degree

Statistics

International

Norway 4

Operational

Director/Board Member 2
Corporate Officer/Principal 2
Chief Executive Officer 1

Sectoral

Health Technology 3
Consumer Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies1
LYTIX BIOPHARMA

Health Technology

Private companies1
Prophylix AS
Logo Prophylix AS

Prophylix AS

Pharmaceuticals: MajorHealth Technology

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Øystein Rekdal
  4. Experience